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Understanding the mechanisms that maintain protective antibody levels after immunisation is important for vaccine
design. In this study, we have determined the kinetics of plasma and memory B cells detectable in the blood of
cattle immunised with model T-dependent or T-independent antigens. Immunisation with the T-D antigen resulted
in an expansion of TNP-specific plasma cells post-TNP primary and booster immunisations, which was associated
with increased titres of TNP-specific IgG antibodies. Although no TNP-specific memory B cells were detected in the
T-D group following the primary immunisation, we detected an increase in the number of TNP-specific memory B
cells post-TNP boost. In contrast, no TNP-specific plasma or memory B cells were detected after primary or
secondary immunisation with the T-I antigen. We then investigated if immunisation with a third party antigen
(tetanus toxin fragment C, TTC) would result in a bystander stimulation and increase the number of TNP-specific
plasma and memory B cells in the T-D and/or T-I group. TTC immunisation in the T-D group resulted in a small
increase in the number of TNP-specific plasma cells post-TTC primary immunisation and boost, and in an increase
in the number of TNP-specific memory B cells post-TTC boost. This bystander effect was not observed in the
animals previously immunised with the T-I antigen. In conclusion, the present study characterised for the first time
the B cell response in cattle to immunisation with T-D and T-I antigens and showed that bystander stimulation of
an established T-D B cell memory response may occur in cattle.Introduction
Antibodies play a vital role in preventing viral infection
and offer protection against subsequent re-challenge,
providing protective antibody titres are maintained [1].
The maintenance of long-term protective antibodies fol-
lowing primary antigen exposure is provided by a com-
bination of memory B cells and long-lived plasma cells,
at least in mice [2]. On the basis of their size, nature and
structure, antigens can induce T cell dependent (T-D) or
T cell independent (T-I) immune responses [3]. We
have previously shown that the B cell ELISPOT assay
can be used to detect and enumerate antigen-specific
plasma and memory B cells in cattle immunised with* Correspondence: bryan.charleston@iah.ac.uk
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reproduction in any medium, provided the orovalbumin, a T-dependent (T-D) antigen [4]. However,
there are currently no data available regarding the kinet-
ics of these cells in the blood of cattle immunised with a
T-independent (T-I) antigen.
Antigens that induce T-cell help to orchestrate a high
affinity class-switched serological response are termed
T-D antigens. During a T-D antigenic challenge, a small
proportion of activated B cells differentiate into short-
lived plasma cells within the T-cell regions of the second-
ary lymphoid organs and secrete low affinity antibodies
for a short period of time [5]. The remaining activated B
cells are recruited to the B cell follicles to form germinal
centres, where the process of somatic hypermutation
occurs (improving the B cell receptor affinity for their
cognate antigen by 1 to 2 orders of magnitude) [6,7];
both long-lived plasma cells and memory B cells are
generated and selected. Long-lived plasma cells mi-
grate to specific niches within the bone marrow [8] andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for prolonged periods [10]. In contrast, memory B cells
continuously circulate without secreting antibodies.
Conversely, T-I antigens are able to initiate a sero-
logical response in the absence of T-cell help. There are
two types of T-I antigens, type 1 are polyclonal B cell sti-
mulants and type 2 are non-polyclonal stimulants. Type
2 T-I antigens possess highly organised, repeating struc-
tures that are able to activate naïve B cells in the absence
of CD4+ T cell help, by cross linking multiple B cell
receptors (BCRs) on the naïve B cell surface [11,12]. A
second signal is required by the activated B cell to
stimulate antibody production, either via TLR stimula-
tion [3,13] or complement activation and CD21 stimula-
tion [12]. However, whilst B cells can be activated by
type 2 T-I antigens, development of long-term memory
B cells to these antigens is limited, particularly in chil-
dren under 2 years of age [14] and in neonatal mice
[13]. It has been demonstrated that T-I antigens, such as
polysaccharides, can be altered, via conjugation to a pro-
tein carrier, producing a T-D response, which results in
the induction of sustained immunological memory
[15,16].
Many pathogens contain both T-I and T-D antigens,
virus capsids that have a repetitive/non-random struc-
ture, such as foot-and-mouth disease virus, FMDV, with
antigenic epitopes spaced 5–10 nm apart) tend to prefer-
entially generate a T-I immunological response [1,16].
Indeed, T cell depletion studies in cattle have shown that
FMDV invokes a largely type 2 T-I response to struc-
tural proteins [17].
Upon re-exposure to a specific antigen [18] or upon
polyclonal stimulation [10], memory B cells differentiate
into plasma cells and secrete antibodies. Several
mechanisms of polyclonal memory B cell stimulation
have been previously described in mice and humans, in-
cluding “bystander stimulation” from activated bystander
CD4+ T-cells via cytokines [10], from microbial products
via TLR stimulation (e.g. CpG DNA and LPS) [10], or
from other B cell-activating molecules such as BAFF,
APRIL and C4bp that are able to drive the differenti-
ation of memory B cells into plasma cells in a T-
independent manner [19]. This mechanism of “bystander
stimulation”, thought to be an antigen-independent
mechanism for the continuous replenishment of the
plasma cell pool and thereby maintenance of protective
antibody titres [10], has never been described in cattle.
In the present study, we assessed and compared the
kinetics of plasma and memory B cells generated in
cattle immunised with either a T-D antigen (the hap-
ten 2,4,6-trinitrophenyl, TNP, conjugated to chicken
gamma globulin, TNP-CGG) or type 2 T-I antigen
(TNP conjugated to aminoethylcarboxymethyl-FICOLL,
TNP-AECM-FICOLL). We also investigated whether asubsequent immunisation with a third party antigen
exerted an effect upon the B cell response previously
established to either the T-D or type 2 T-I antigen.
Materials and methods
Calves and immunisation protocols
Ten male 8-month-old conventionally reared Holstein-
Friesian calves (Bos Taurus, Institute for Animal
Health, Compton, UK) were split into two randomly
selected groups of five. In the first group, each calf
was subcutaneously immunised with 3 mg of the hap-
ten 2,4,6-trinitrophenyl (TNP) conjugated to the T-D
antigen chicken gamma globulin (TNP-CGG, Biosearch
technologies, Novato, CA, USA) in QuilA adjuvant
(Superfos Speciality Chemical a/s, Vedbaek, Denmark).
In the second group, each calf was subcutaneously
immunised with 3 mg of TNP conjugated to the T-I
antigen aminoethylcarboxymethyl-FICOLL (TNP-AECM-
FICOLL, Biosearch technologies, Novato, CA, USA) in
QuilA adjuvant. All calves were boost-immunised 29-days
later with the same immunising antigens, as described
above (TNP-CGG in the T-D group and TNP-AECM-
FICOLL in the T-I group). At day 134 post-primary
immunisation (pi) all calves, from both groups, were sub-
cutaneously immunised with 3 mg of tetanus toxin frag-
ment C (TTC, PX’Therapeutics, Grenoble, France) in
incomplete Freund’s adjuvant (IFA, Difco Laboratories,
Detroit, MI, USA). Subsequently, all animals were boosted
with TTC and IFA at day 197 pi. A group of control ani-
mals were given a primary and booster immunisation of
adjuvant alone (including IFA). These animals showed no
detectable antigen-specific plasma, memory B cells or IgG
titres throughout the study. Heparinised peripheral blood
and serum samples were taken from all animals at various
time points following the immunisations. All experi-
ments were approved by the Institute’s ethical review
process and were in accordance with national guidelines
on animal use.
Bovine peripheral blood mononuclear cell (PBMC)
isolation
Bovine PBMCs were isolated from the heparinised per-
ipheral blood samples using density gradient centrifuga-
tion. The blood samples were diluted 1:2 using
Dulbecco’s phosphate buffered saline (dPBS, Invitrogen),
layered over HistopaqueW 1.083 g/mL (Sigma-Aldrich)
and centrifuged for 30 min at 1200 × g. The mono-
nuclear cell layer was recovered after centrifugation and
remaining red cells were lysed using ammonium chlor-
ide lysis buffer (155 mM NH4Cl, 10 mM KHCO3,
0.1 mM EDTA, pH7.2). After two further washing steps
using dPBS, the PBMCs were enumerated using a Neu-
bauer haemocytometer (Hawksley, Lancing, UK). A frac-
tion of the enumerated fresh PBMCs were diluted to the
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for the detection of plasma cells.
Memory B cell culture
An “ELISPOT medium” was used in all experiments
aimed at quantifying plasma and memory B cells and
consisted of RPMI 1640 with L-Glutamine and 25 mM
Hepes (Invitrogen, Paisley, UK) supplemented with peni-
cillin (100 units/mL), streptomycin (100 μg/mL), 1×
non-essential amino acids (Sigma-Aldrich, Gillingham,
UK), 1 mM sodium pyruvate and 15% heat-inactivated
horse serum (Sigma-Aldrich).At the indicated time-
points, some PBMCs were cultured as described below
to induce the terminal differentiation of memory B cells
into antibody secreting cells (ASC) prior to their detec-
tion by ELISPOT assay. Briefly, 2 × 107 bovine PBMCs
were cultured for 6 days in 20 mL of ELISPOT media
(final PBMC concentration: 1 × 106/mL) supplemented
with 5 μg/mL pokeweed mitogen (PWM, Sigma-
Aldrich), 10 μg/mL anti-bovine CD40 mAb (ILA158,
kindly donated by ILRI, Kenya), 20 ng/mL recombinant
human IL-2 (AMS Biotechnology Ltd, Abingdon, UK)
and 7.3 units/mL bovine IL-10 (kindly donated by Dr G
Entrican, Moredun Research Institute, Midlothian, UK).
At the end of the culture period, the 6 day-cultured
PBMC were recovered, washed twice in ELISPOT
media, enumerated and stored on ice until being used
for the detection of induced ASC by ELISPOT assay.
Plasma and memory B cell quantification by ELISPOT
MultiScreen™–HA plates (Millipore, Watford, UK) were
coated with either 0.25 μg/mL TNP-Ovalbumin (TNP-
Ova), 1/1000 Chicken serum (containing CGG, Sigma-
Aldrich) or 10 μg/mL TTC (PX’Therapeutics) in 0.1 M
carbonate buffer (pH 9.6) for 2 h at 37°C. Plates were
then washed 5 times in PBS and then blocked using 4%
dried milk (Marvel, Premier Foods, St Albans, UK) in
PBS. Following blocking, the plates were washed 5 times
in PBS and stored at 4°C until required.
Fresh or 6 day-cultured PBMCs were suspended at
5 × 106 cells/mL and 1:2 serial dilutions were performed
in ELISPOT medium down to 1.5 × 105 cells/mL. 100
μL/well of each suspension (in duplicate) was then
incubated on the coated plates overnight at 37°C in a
5% CO2 incubator. Subsequently, the PBMCs were
washed from the plates 5 times using PBS containing
0.05% Tween20 (Sigma-Aldrich). 100 μL per well of a
1/1000 dilution of sheep anti-bovine IgG conjugated to
horseradish peroxidase (AbD Serotec, Kidlington, UK)
was then added to the plates for 3 h at room
temperature. Following the incubation step, the plates
were again washed 5 times using PBS containing 0.05%
Tween20. Detection was performed by the addition of
100 μL/well of 3-amino-9-ethylcarbonate substrate(AEC, Merck, Darmstadt, Germany) and subsequent in-
cubation at room temperature for 1 h. The reaction
was stopped by washing the plates with tap water and
allowing them to dry overnight at room temperature.
Enumeration of the red coloured spots on the dried
ELISPOT plates was performed using the automated
AID ELIspot reader (Autoimmun Diagnostika GmbH,
Strasbourg, Germany). Each individual “spot” was used
as an indicator for an ASC. The ELISPOT results were
manually validated for false positives and expressed as
ASC number per 106 PBMCs for plasma cells and
induced-ASC number per 106 cultured PBMCs for
memory B cells (mean of duplicates). During the ELIspot
data analysis any well with less than 2 spots was consid-
ered to be negative and were treated as having zero
ASCs detected (minimum sensitivity: 4 ASCs per 1 × 106
PBMCs). There was very little variance (< 17%) shown
between the duplicate observations within each animal.Enzyme-linked immunoabsorbent assays (ELISA)
96-well plastic plates (BD biosciences, Oxford, UK) were
coated for 1 h at room temperature with 100 μL/well of
either 20 μg/mL TNP-OVA (Biosearch Technologies) or
10 μg/mL TTC (PX’Therapeutics) in carbonate buffer.
Following incubation the plates were washed 5 times in
PBS containing 1% Tween20 (Sigma-Aldrich). The plates
were then blocked for 1 h using 100 μL/well of PBS con-
taining 1% Tween20 and 4% dried milk (blocking buffer),
followed by a washing step, as described above. Serum
samples (in duplicate) were serially diluted 1:3 in block-
ing buffer starting at 1/50 dilution, and 100 μL per well
of each diluted serum was added before incubating the
plate for 1 h at room temperature. For determination of
the plate background optical density (OD) values, some
wells were incubated with blocking buffer alone. Follow-
ing the incubation, the plates were washed and incu-
bated for 1 h at room temperature after addition of 100
μL/well of 1/100,000 dilution of sheep anti-bovine IgG
conjugated to horseradish peroxidase (AbD Serotec).
Following washing, the plates were incubated for 10 min
with 3,3’,5,5’-tetra-methyl benzidine (TMB, Sigma-
Aldrich) substrate at room temperature. The reaction
was stopped by the addition of 50 μL of 1.2 M H2SO4.
The OD values at 450 nm and 690 nm were determined,
for each well using a Biotek ELx808 absorbance plate
reader (Biotek, Winooski, VT, USA). The antigen-
specific antibody titres were calculated as follows: the
log10 values of sample dilutions were plotted against the
log10 values of sample OD and a regression analysis was
performed on the linear part of the curve allowing the
endpoint titre to be calculated using an OD of twice the
background. Results were expressed as the mean of du-
plicate determinations.
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Data for the number of antigen-specific IgG ASCs (for
plasma and memory B cells) were log + 1 transformed,
then analysed using mixed linear models including time
(as a factor) and vaccine (TNP-CGG or TNP-AECM-
Ficoll), and an interaction between them as fixed effects
and between animals as a random effect. Model selec-
tion proceeded by stepwise deletion of non-significant
(P > 0.05) terms as judged by likelihood ratio tests. Data
were considered significant if the calculated P values
were < 0.05.
Results
Antibody titre kinetics following primary and booster
immunisations with a T-D versus T-I antigen
The TNP-specific IgG titres in the T-D (TNP-CGG) and
the T-I (TNP-AECM-FICOLL) groups began to increase
from day 6–8 post-primary TNP immunisation (pi) and
peaked at approximately day 10 pi for the T-D group
(8905 ± 1417, n= 5) and approximately day 22 pi for the
T-I group (1664 ± 314, n = 5) (Figure 1). Subsequently,
the TNP-specific IgG titres in both groups also showed
an increase starting from day 4 post-TNP boost that
peaked at day 12 post-TNP boost (T-D group:Figure 1 Kinetics of TNP-specific Ig titres following primary and boos
subcutaneously immunised with 3 mg TNP-CGG or TNP-AECM-FICOLL in Q
The dotted vertical line indicates when the booster TNP-CGG/TNP-AECM-FI
at various time-points following these injections and TNP-specific IgG (diam
ELISA in calves from the T-D group (open symbols) or T-I group (filled sym
individual calves in each group± SEM, n= 5.162 103 ± 33 339; T-I group: 11 226 ± 3573, day 41 pi,
n= 5) (Figure 1). At most time-points, the T-I group
TNP-specific IgG titres were over five times lower than
the T-D group titres (Figure 1). The T-D group TNP-
specific IgM titres showed an increase from day 6 pi,
peaked at day 8 pi (24 635 ± 7854, n= 5) and remained
elevated until day 16 pi (34 838 ± 18 730, n= 5) (Figure 1).
Following boost immunisation, the IgM titres in the
T-D group peaked at day 6 to 8 post-TNP boost
(46 637 ± 17 044, day 37 pi, n = 5) before declining grad-
ually (Figure 1). The T-I group also showed an increase
in TNP-specific IgM titres, peaking 6 to 8 days after
both the primary (2120 ± 867, day 8 pi, n = 5) and boost
(4694 ± 578, day 37 pi, n = 5) TNP immunisations
(Figure 1).
Plasma cell and memory B cell kinetics following primary
and booster immunisations with a T-D versus T-I antigen
In the T-D group, there were no detectable TNP-specific
plasma cells post primary immunisation. However, a
burst of TNP-specific plasma cells was observed at days
3–5 post-TNP boost (280 ± 149 TNP-specific ASC per
106 PBMC, day 33 pi, n= 5) (Figure 2). Although no
TNP-specific memory B cells were detected in the T-Dt immunisations with TNP-conjugated antigens. Five calves were
uilA then boosted 29 days later with the same immunising antigens.
COLL immunisations were given (day 29 pi). Blood samples were taken
ond symbols) and IgM (square symbols) titres were determined by
bols). Results are expressed as the mean of determinations from
Figure 2 TNP-specific plasma and memory B cell detection post-boost immunisation with TNP-CGG (T-D group). Five calves were
subcutaneously immunised with 3 mg TNP-CGG in QuilA then boosted 29 days later with the same immunising antigen. The dotted vertical line
indicates when the booster TNP-CGG immunisation was given (day 29 pi). Blood samples were taken at various time-points following the
immunisations. TNP-specific IgG, plasma cell (filled circles, left-axis) and memory B cell (open circles, right-axis) numbers were determined by B
cell ELISPOT. Results were expressed as ASC per 106 PBMC for plasma cells and induced ASC per 106 cultured PBMC for memory B cells (mean of
determinations from individual calves in each group, n= 5).
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shown), TNP-specific memory B cells were detected
from day 3 post-TNP boost, peaking at day 6–7 post-
TNP boost (2080 ± 1218 TNP-specific induced ASC per
106 cultured PBMCs, day 36 pi, n= 5) (Figure 2) and
were still detectable at day 34 post-TNP boost (22 ± 3
TNP-specific induced ASC per 106 cultured PBMCs, day
63 pi, n= 5, data not shown). At day 34 post-TNP boost,
we also assessed the B cell memory response to CGG
using chicken serum as a positive control within the
assay. CGG-specific memory B cells were only detected
in the T-D group and were approximately 5–6 fold more
numerous than TNP-specific memory B cells (130 ± 40
CGG-specific induced ASC per 106 cultured PBMCs,
day 63 pi, n= 5, data not shown). In the T-I group, TNP-
or CGG-specific plasma or memory B cells were not
detected at any time-point following either the primary
or booster TNP immunisation.
Immunisation with TTC induces an increase in
TTC-specific plasma and memory B cells
Each of the calves from both the T-D and T-I groups
were immunised with a third party antigen (TTC) at day
134 pi and were re-immunised with TTC at day 197 pi.
A burst of TTC-specific IgG plasma cells was detected
between day 7 to 14 post-primary TTC immunisation in
all animals (45 ± 17 TTC-specific ASC per 106 PBMCs,day 148 pi, n= 10) (Figure 3A). Following boost-
immunisation with TTC at day 197 pi, TTC-specific
plasma cells were detected from day 3 post-TTC boost
and peaked at day 4 to 5 post-TTC boost (740 ± 126
TTC-specific ASC per 106 PBMCs, day 202 pi, n= 10)
(Figure 3A) (p < 0.001). A small burst of IgG TNP- (2 out
of 5 calves) and CGG-(5 out of 5 calves) specific plasma
cells was also observed in the T-D group at days 3 to 14
post-TTC primary immunisation (2 out of 5 calves
showed 6 and 4 TNP-specific ASC per 106 PBMCs, day
141 pi, n = 2 and 10 ± 6 CGG-specific ASC per 106
PBMCs, day 141 pi, n= 5). Another small burst of CGG-
specific plasma cells was observed in 3 out of 5 calves at
days 3 to 5 post-TTC boost (3 out of 5 calves showed 4, 5
and 11 CGG-specific ASC per 106 PBMCs, day 201 pi,
n = 3) (p < 0.05) in the animals that had previously been
immunised with the T-D antigen, TNP-CGG (Figure 3A).
All of the animals demonstrated a steady increase in the
number of TTC-specific memory B cells from day 28
post-TTC primary immunisation (13 ± 8 TTC-specific
induced ASC per 106 cultured PBMCs, day 162 pi,
n = 10) (Figure 3B). The number of TTC-specific mem-
ory B cells increased significantly following the boost im-
munisation with TTC, peaking at days 6 to 8 post-TTC
boost (4111 ± 495 TTC-specific induced ASC per 106
cultured PBMCs, day 205 pi, n= 10) and then gradually
declining (Figure 3B). TTC-specific memory B cells were
Figure 3 Kinetics of antigen-specific IgG secreting plasma cells and memory B cells post-TTC immunisation. At day 134 post-primary
TNP-conjugated immunisation, all calves were subcutaneously immunised with 3 mg TTC in IFA then boosted 63 days later with the same
immunising antigen. Blood samples were taken at various time-points following these immunisations. The time of primary and boost TTC
immunisations are indicated by vertical dotted lines (day 134 and 197 pi, respectively). Antigen-specific IgG, plasma cell (A) and memory B cell (B)
numbers were determined by B cell ELISPOT and are identified as follows: CGG-specific (open triangle), TTC-specific (crosses) and TNP-specific
(closed triangle) IgG secreting ASCs. Results were expressed as ASC per 106 PBMC for plasma cells and induced ASC per 106 cultured PBMC for
memory B cells (mean of determinations from individual calves in each group for the TNP- and CGG-specific responses, n= 5, and mean of
determinations from all calves for the TTC-specific responses, n= 10). a = p< 0.05, b = p< 0.001.
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(482 ± 110 TTC-specific induced ASC per 106 PBMCs,
day 218 pi, n = 10). There was also an increase in the
number of TNP- and CGG-specific memory B cells in
calves previously immunised with the T-D antigen at day
6–8 post-TTC boost (8 ± 5 TNP-specific induced ASC
per 106 cultured PBMCs and 200 ± 129 CGG-specific
induced ASC per 106 cultured PBMCs, day 205 pi, n = 5)
(Figure 3B).Immunisation with TTC induces an increase in
TTC-specific IgG titres in calves
All animals demonstrated an increase in TTC-specific
IgG titres from day 14 post-TTC primary immunisation
(17 074 ± 5889, day 148 pi, n= 10) and day 7 post-TTC
boost (1 004 210 ± 594 085, day 204 pi, n= 10) (Figure 4).
There was a small, although not statistically significant,
increase in TNP-specific IgG titres at day 3 post-TTC
primary immunisation in the T-D group (22 794 ± 7762,
Figure 4 Kinetics of TNP- and TTC-specific IgG titres following primary and boost TTC immunisations. TNP-specific IgG titres in calves
from the T-D group (open diamonds) or T-I group (filled diamonds) and TTC-specific IgG titres in all calves (cross symbols) were determined by
ELISA. The dotted vertical lines indicate when the primary and boost TTC immunisations were administered (days 134 and 197 pi, respectively).
Results are expressed as the mean of determinations from individual calves in each group for the TNP-specific responses (n=5) and the mean of
determinations from all calves for the TTC-specific responses (n= 10).
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mary immunisation (12 868 ± 2913, day 134 pi, n= 5)
(Figure 4). There was also a small increase in TNP-
specific IgG titres at day 3 post-TTC boost in the T-D
group (6186 ± 2675, day 200 pi, n= 5) as compared to
day 0 post-TTC boost (5327 ± 1962, day 197 pi, n= 5). In
the T-I group; TNP-specific IgG titres were not
increased following either the TTC primary or boost im-
munisation (Figure 4).
Discussion
This is the first time the magnitude and the kinetics of
the T-D and T-I2 antigen specific B cell response has
been described in cattle. Briefly, the response to the T-D
antigen was characterised by an expansion of TNP-
specific plasma cells peaking at day 7 post-TNP primary
immunisation, which was associated with a subsequent
increase in the titre of TNP-specific IgG antibodies. Fol-
lowing booster immunisation, a larger TNP-specific
plasma cell burst was detected at day 3 to 5 post-TNP
boost, and was similarly associated with a larger increase
in TNP-specific IgG titres. The timing and magnitude of
the T-D antigen-specific plasma cell bursts is in agree-
ment with the findings of a previously published study,
in which calves were immunised with another T-Dmodel antigen, ovalbumin [4]. Moreover, a plasma cell
burst has also been previously detected (with identical
kinetics: 6 to 7 days post-primary immunisation) in
humans following their immunisation with a number of
different antigens, such as inactivated influenza virus
[20], respiratory syncytial virus [21], serogroup C menin-
gococcal polysaccharides [15] and tetanus toxoid [10].
The timing and magnitude of the secondary plasma cell
burst and increased IgG response, i.e. a rapid and larger
secondary response, is in keeping with the central
dogma of immunological priming by a T-D antigen
[15,22].
There was an increase in the number of TNP-specific
memory B cells from day 3 post-TNP-CGG boost that
peaked at day 6 to 7 post-TNP boost. TNP-specific and
CGG-specific memory B cells were still detectable in the
blood of calves from the T-D group at day 34 post-TNP
boost. The timing and magnitude of this T-D antigen
specific response, following booster immunisation, is in
keeping with other previously published data [4]. Al-
though no TNP-specific memory B cells were detected
in the T-D group following the primary immunisation.
Previous studies in both humans and cattle have shown
low numbers of antigen-specific memory B cells follow-
ing primary immunisation with a T-D antigen [4,15].
Grant et al. Veterinary Research 2012, 43:68 Page 8 of 9
http://www.veterinaryresearch.org/content/43/1/68The rapid induction of TNP-specific plasma cells from
day 3 post-TNP boost and the associated increase in
TNP-specific IgG antibody titres observed in the T-D
group suggests that a number of TNP-specific memory
B cells were indeed generated after primary immunisa-
tion, but the quantities in blood were below the detec-
tion levels of our ELISPOT assay.
T-independent antigens are unable to prime indivi-
duals for a secondary immune response [15]. In this
study the T-I2 group showed no detectable TNP-specific
plasma or memory B cells, after either the primary or
booster immunisation with TNP-AECM-FICOLL. Des-
pite the lack of detectable antigen-specific plasma or
memory B cells in the blood, there was a small increase
in TNP-specific IgG titres in this group following pri-
mary and booster immunisations. It is likely that this in-
crease in antibody titres results from the in situ
generation of short-lived plasma cells, as previously
described [5]. These findings are in keeping with Fink
et al. who suggest that the absence of specific T cell help
results in reduced germinal centre formation, which pro-
motes an extra follicular plasma cell response, favouring
short-lived plasma cell formation [22]. Kelly et al. have
also shown that following primary immunisation with a
T-I2 antigen, serogroup C meningococcal capsular poly-
saccharide, very low/undetectable numbers of antigen-
specific memory B cells were generated [15]. The results
from the present study shows that in cattle the kinetics
and magnitude of the T-I2 antigen-specific plasma and
memory B cell response is similar to that of the human
and mouse.
Immunisation with the third party antigen (TTC) in
this study resulted in similar TTC-specific plasma and
memory B cell kinetics that have been previously
described for other TD antigens [4,15,20,21]. Briefly, a
burst of TTC-specific plasma cells was detected from
day 7 to 14 post-TTC primary immunisation and from
day 3 to 5 post-TTC boost in all animals. Interestingly,
we found that the TTC-specific plasma cell bursts in the
T-D group were also associated with a small increase in
the number of TNP- and CGG-specific plasma cells
post-TTC primary immunisation and/or boost. These
results are consistent with those previously published
by Bernasconi et al., which demonstrated a bystander
polyclonal differentiation of memory B cells into plasma
cells specific for various recall antigens (Toxoplasma
gondii and measles virus) following the immunisation
of humans with an unrelated T-D antigen (tetanus
toxoid) [10].
There was a steady increase in the number of TTC-
specific memory B cells post-TTC primary immunisation
followed by at least a 14 fold increase in the number of
these cells post-TTC boost. The T-D group also showed
an increase in the number of TNP- and CGG-specificmemory B cells only post-TTC boost (at day 6–8 post-
TTC boost). Based on the timing of emergence of the
TNP- and CGG memory B cells, it is unlikely that these
memory B cells were generated from newly activated
naïve B cells, but instead suggests that pre-existing
TNP- and CGG-specific memory B cells were subjected
to one (or more) round(s) of antigen-independent (by-
stander) proliferation within the T-cell regions of the
draining lymph node. This bystander stimulation of T-D
antigen-specific plasma and memory B cells may provide
a mechanism for maintaining long term T-D antigen-
specific antibody titres.
In conclusion, the present study showed that by-
stander stimulation of an established T-D B cell memory
response may occur in cattle, providing a possible mech-
anism of maintaining protective antibody titres for long
periods of time. Our findings also provided a better
characterisation of the key differences between T-D and
T-I immune responses in cattle. However, as highlighted
by Fink et al., more studies are required to further eluci-
date the mechanisms of the T-D and T-I2 activation of
antigen-specific plasma cells [22]. As demonstrated by
this study and others [4,15,22], clearly the timing and
magnitude of the antigen-specific plasma cell response is
dependent on a number of factors, including the nature
of the immunising antigen [22].
This knowledge will be particularly useful in elucidat-
ing the B cell response to the largely T-I antigen, FMDV
[17]. Indeed as mentioned previously, most natural
pathogens contain both T-I and T-D antigens, but
viruses such as FMDV tend to preferentially generate a
T-I immunological response [17]. FMDV is a highly con-
tagious virus infecting cloven-hoofed animals, leading to
skin erosions of the cutaneous mucosa. The virus has a
significant global socio-economic impact, and the main-
tenance of FMDV-free status is critical for the free trade
of animals and animal products [23]. One of the main
methods of FMDV disease control and eradication is
through vaccination [23]. The current FMDV vaccine
only promotes short-term humoral immunity (presum-
ably due to the essentially T-I nature of this virus), and
regular repeat vaccinations are used to maintain protect-
ive IgG antibody titres [24], due to the lack of long-term
immunological protection. Therefore, future studies in-
cluding a more detailed assessment of the B cell re-
sponse against FMDV in cattle could provide important
data to underpin a better evaluation of novel candidate
vaccines that induces a robust and sustained T-D rather
than a T-I response.
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